openPR Logo
Press release

Axillary Hyperhidrosis Market Expected to Experience Major Growth by 2032, According to DelveInsight | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation

08-27-2024 08:49 PM CET | Health & Medicine

Press release from: DelveIinsight Business Research

Axillary Hyperhidrosis Market Expected to Experience Major

DelveInsight's "Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Axillary Hyperhidrosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Axillary Hyperhidrosis Market Forecast
https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Axillary Hyperhidrosis Market Report:
• The Axillary Hyperhidrosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In January 2024, InMode MD Ltd. offers the InMode Pro System with the Morpheus8 Applicator, a computerized device that produces radio frequency energy utilizing Fractional RF technology. The Morpheus8 Applicator, equipped with a 24-pin tip, is specifically designed for treating primary hyperhidrosis in the underarm area.
• There are currently too few and insufficient epidemiologic data on hyperhidrosis to establish accurate prevalence or impact estimates. According to DelveInsight analysts, there were 10,491,560 cases of axillary hyperhidrosis (AH) in the US as a whole
• Based on the HDSS scale, the degree of axillary hyperhidrosis was assessed. According to DelveInsight, 1,584,618 people had non-severe symptoms and roughly 1,716,670 people had severe symptoms in 2021
• In the US, there were 3,301,288 diagnosed cases of axillary hyperhidrosis (AH) overall in 2021.
• The prevalence of primary axillary hyperhidrosis in the population of Japan aged 5-64 years is 5.75% (males, 6.60%; females, 4.72%), according to a study by Murota et al. (2021).
• Key Axillary Hyperhidrosis Companies: Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation, Persōn & Covey, Stratus Pharmaceuticals, Journey Medical Corporation, Allergan, AbbVie, Brickell Biotech, Dermavant Sciences, Dermata Therapeutics, Viatris, Candesant Biomedical, and others
• Key Axillary Hyperhidrosis Therapies: Sofpironium Bromide, VASE, Glycopyrronium Bromide, Meditoxin, glycopyrronium Topical Wipesl, and others
• The Axillary Hyperhidrosis epidemiology based on gender analyzed that in the US, out of the total diagnosed cases of Axillary Hyperhidrosis in 2021, 93% accounted for primary hyperhidrosis and 7% accounted for secondary hyperhidrosis
• The Axillary Hyperhidrosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Axillary Hyperhidrosis pipeline products will significantly revolutionize the Axillary Hyperhidrosis market dynamics.

Axillary Hyperhidrosis Overview
Axillary hyperhidrosis is a medical condition characterized by excessive sweating in the underarm (axillary) area. This condition goes beyond the normal sweating that helps regulate body temperature and can be persistent and unpredictable. People with axillary hyperhidrosis often experience significant discomfort and embarrassment due to the constant wetness, which can interfere with daily activities, social interactions, and overall quality of life.

Get a Free sample for the Axillary Hyperhidrosis Market Report:
https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Axillary Hyperhidrosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Axillary Hyperhidrosis Epidemiology Segmentation:
The Axillary Hyperhidrosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Axillary Hyperhidrosis
• Prevalent Cases of Axillary Hyperhidrosis by severity
• Gender-specific Prevalence of Axillary Hyperhidrosis
• Diagnosed Cases of Episodic and Chronic Axillary Hyperhidrosis

Download the report to understand which factors are driving Axillary Hyperhidrosis epidemiology trends @ Axillary Hyperhidrosis Epidemiology Forecast
https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Axillary Hyperhidrosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Axillary Hyperhidrosis market or expected to get launched during the study period. The analysis covers Axillary Hyperhidrosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Axillary Hyperhidrosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Axillary Hyperhidrosis Therapies and Key Companies
• Sofpironium bromide (BBI-4000): Botanix Pharma
• VASER: Sound Surgical Technologies, LLC.
• Glycopyrronium Bromide: Dr. August Wolff GmbH
• Meditoxin: Medy-Tox
• glycopyrronium Topical Wipes: Journey Medical Corporation

Discover more about therapies set to grab major Axillary Hyperhidrosis market share @ Axillary Hyperhidrosis Treatment Market
https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Axillary Hyperhidrosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Axillary Hyperhidrosis Companies: Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation, Persōn & Covey, Stratus Pharmaceuticals, Journey Medical Corporation, Allergan, AbbVie, Brickell Biotech, Dermavant Sciences, Dermata Therapeutics, Viatris, Candesant Biomedical, and others
• Key Axillary Hyperhidrosis Therapies: Sofpironium Bromide, VASE, Glycopyrronium Bromide, Meditoxin, glycopyrronium Topical Wipes, and others
• Axillary Hyperhidrosis Therapeutic Assessment: Axillary Hyperhidrosis current marketed and Axillary Hyperhidrosis emerging therapies
• Axillary Hyperhidrosis Market Dynamics: Axillary Hyperhidrosis market drivers and Axillary Hyperhidrosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Axillary Hyperhidrosis Unmet Needs, KOL's views, Analyst's views, Axillary Hyperhidrosis Market Access and Reimbursement

To know more about Axillary Hyperhidrosis companies working in the treatment market, visit @ Axillary Hyperhidrosis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Axillary Hyperhidrosis Market Report Introduction
2. Executive Summary for Axillary Hyperhidrosis
3. SWOT analysis of Axillary Hyperhidrosis
4. Axillary Hyperhidrosis Patient Share (%) Overview at a Glance
5. Axillary Hyperhidrosis Market Overview at a Glance
6. Axillary Hyperhidrosis Disease Background and Overview
7. Axillary Hyperhidrosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Axillary Hyperhidrosis
9. Axillary Hyperhidrosis Current Treatment and Medical Practices
10. Axillary Hyperhidrosis Unmet Needs
11. Axillary Hyperhidrosis Emerging Therapies
12. Axillary Hyperhidrosis Market Outlook
13. Country-Wise Axillary Hyperhidrosis Market Analysis (2019-2032)
14. Axillary Hyperhidrosis Market Access and Reimbursement of Therapies
15. Axillary Hyperhidrosis Market Drivers
16. Axillary Hyperhidrosis Market Barriers
17. Axillary Hyperhidrosis Appendix
18. Axillary Hyperhidrosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Axillary Hyperhidrosis Pipeline https://www.delveinsight.com/report-store/axillary-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Axillary Hyperhidrosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Axillary Hyperhidrosis market. A detailed picture of the Axillary Hyperhidrosis pipeline landscape is provided, which includes the disease overview and Axillary Hyperhidrosis treatment guidelines.

Axillary Hyperhidrosis Epidemiology https://www.delveinsight.com/report-store/axillary-hyperhidrosis-epidemiology-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Axillary Hyperhidrosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Axillary Hyperhidrosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Retinoblastoma Market
https://www.delveinsight.com/report-store/retinoblastoma-market
DelveInsight's "Retinoblastoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Retinoblastoma, historical and forecasted epidemiology as well as the Retinoblastoma market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-6mm-market
DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom).

Skin Burns Market
https://www.delveinsight.com/report-store/skin-burns-market
DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market
DelveInsight's "Thymus Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Thymus Cancer, historical and forecasted epidemiology as well as the Thymus Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Substance Use Disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market
DelveInsight's "Substance Use Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance Use Disorder, historical and forecasted epidemiology as well as the Substance Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Tongue Cancer Market
https://www.delveinsight.com/report-store/tongue-cancer-market
DelveInsight's "Tongue Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tongue Cancer, historical and forecasted epidemiology as well as the Tongue Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Axillary Hyperhidrosis Market Expected to Experience Major Growth by 2032, According to DelveInsight | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation here

News-ID: 3636757 • Views:

More Releases from DelveIinsight Business Research

Advanced Renal Cell Carcinoma Market Report 2034: Epidemiology Data, Therapies, Latest Drug Approvals | DelveInsight | Pfizer, AbbVie, Bristol-Myers Squibb, Abbott, Takeda, Amgen, Novartis, AVEO Pharma, Calithera Biosciences, Inc, Merck Sharp & Dohme LLC
Advanced Renal Cell Carcinoma Market Report 2034: Epidemiology Data, Therapies, …
DelveInsight's "Advanced Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as well as the Antibody Drug Conjugates market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Advanced Renal Cell Carcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Advanced Renal
PCSK9 Inhibitors Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Novo Nordisk, AstraZeneca, Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotech
PCSK9 Inhibitors Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PCSK9 Inhibitors pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "PCSK9 Inhibitors Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PCSK9 Inhibitors Market. The PCSK9
Metastatic Prostate Cancer Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Curium, Merck/ Orion, Pfizer, AstraZeneca, Telix Pharma, Tavanta Therapeutics, Candel Therapeutics
Metastatic Prostate Cancer Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Prostate Cancer pipeline constitutes 75+ key companies continuously working towards developing 75+ Metastatic Prostate Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Metastatic Prostate Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Metastatic Prostate
Bunion (Hallux Valgus) Market to Expand Significantly by 2034, States DelveInsight Report | Heron Therapeutics, Lotus Clinical Research, Cali Pharma, Grünenthal GmbH, Pacira Pharma, Inc, Mallinckrodt, Cali Pharma
Bunion (Hallux Valgus) Market to Expand Significantly by 2034, States DelveInsig …
DelveInsight's "Bunion Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the Bunion market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Bunion market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bunion Market Forecast https://www.delveinsight.com/sample-request/hallux-valgus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Bunion

All 5 Releases


More Releases for Axillary

Axillary Crutches Market Size 2024 to 2031.
Market Overview and Report Coverage Axillary crutches are commonly used mobility aids to assist individuals in walking when they have difficulty bearing weight on their legs or feet. These crutches are designed with padded axillary supports that rest under the arms and provide support while walking. The Axillary Crutches Market is expected to witness significant growth in the coming years, with a projected CAGR of 12.20% during the forecasted
Massive Growth in Axillary Crutches Market, 2021-2026
(Portland, United States): Big Market Research newly added a research report on the Axillary Crutches Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth in
Axillary Crutches Market - Size, Share, Outlook, and Opportunity
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be
Axillary Crutches Market - Size, Share, Outlook, and Forecast till 2026
A crutch is a mobility aid used to transfer weight from the legs to the upper body. It is majorly used by individuals suffering from mobility dysfunction due to short-term injuries or lifelong disabilities. Axillary crutches are used by placing the pad against the ribcage beneath the armpit and holding the grip, which is below and parallel to the pad. They are usually used to provide support for patients who
Global Axillary Crutches Market: Top Players - Invacare, Stander, Sizewise
​Latest industry research report on: Global Axillary Crutches Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @​https://www.marketresearchreports.biz/sample/sample/1001065 This report studies sales (consumption) of ​Axillary Crutches in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Millennial Medical Ergoactives Cardinal Health AMG Medical Inc/Airgo Carex Graham Field Nova
Global Axillary Crutches Market Research Report 2017
Report Hive Market Research Released a New Research Report of 102 pages on Title " Global Axillary Crutches Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Axillary Crutches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented